Treatment of Benign Prostatic Hyperplasia with Phytosterols
- 1 December 1990
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 66 (6) , 639-641
- https://doi.org/10.1111/j.1464-410x.1990.tb07199.x
Abstract
In a randomised, double-blind study, the preparation Curbicin, obtained from pumpkin seeds and dwarf palm plants (Cucurbita pepo L. and Sabal serrulata), was compared with a placebo in the treatment of symptoms caused by prostatic hyperplasia; 53 patients took part in the study, which was carried out over a 3-month period. Urinary flow, micturition time, residual urine, frequency of micturition and a subjective assessment of the effect of treatment were all significantly improved in the treatment group. No untoward side effects were noted.This publication has 4 references indexed in Scilit:
- Serenoa Refens in the Treatment of Human Benign Prostatic Hypertrophy (BPH)Journal of Urology, 1987
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostateJournal of Steroid Biochemistry, 1984
- β–SITOSTERIN ALS MÖGLIGHER WIRKSTOFF DER SABALFRÜCHTEPlanta Medica, 1966